StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
Huagongshe Open Project:[email protected]KI-Anbindung: llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.7.8
Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 190863Erstellt: 30. Oktober 2026

7-Benzyl-6-methyl-6,7-dihydroquinazolino[3,2-a][1,4]benzodiazepine-5,13-dione

benzomalvin A · Quinazolino[3,2-a][1,4]benzodiazepine-5,13-dione, 6,7-dihydro-6-methyl-7-(phenylmethyl)-, (6S,7S)-

https://huagongshe.com/de/chemical/190863

Molekülstruktur von 7-Benzyl-6-methyl-6,7-dihydroquinazolino[3,2-a][1,4]benzodiazepine-5,13-dione

Identifikatoren & physikalische Daten

CAS No.157047-96-6
SummenformelC24H19N3O2
Durchschnittliche Molmasse381,435 g/mol
Monoisotopische Masse381,14772685 g/mol
SMILESCN1C(=O)c2ccccc2-n2c(nc3ccccc3c2=O)C1Cc1ccccc1
InChIKeyYYWUABJYAOCACI-UHFFFAOYSA-N
PubChem CID190863
DTXSIDDTXSID90935599

Chemische & physikalische Eigenschaften

Siedepunkt599.3±60.0 °C(Predicted)
Dichte1.28±0.1 g/cm3(Predicted)
LagerbedingungenStore at -20°C
LöslichkeitDMF: SolubleDMSO: SolubleEthanol: SolubleMethanol: Soluble
AggregatzustandA solid
pKa (Säurekonstante)-0.46±0.40(Predicted)

Anwendungen & Verwendung

Beschreibung

Benzomalvin A is a fungal metabolite produced by Penicillium. It inhibits yeast α-glucosidase in vitro (IC50 = 383.2 μM). In vivo, benzomalvin A (3.1-31.6 mg/kg) decreases plasma glucose levels in mice following administration of sucrose. It also decreases the plasma glucose postprandial peak in nicotinamide-streptozotocin-induced hyperglycemic mice when administered at a dose of 10 mg/kg. Benzomalvin A also acts as an antagonist of neurokinin-1 (NK1) receptors, inhibiting binding of substance P to guinea pig, rat, and human NK1 (Kis = 12, 42, and 43 μM, respectively).